Life Sciences Reports Archives

Germany Life Science Trend Analysis 2024

While the life sciences industry in Germany saw an overall decline in 2022, 2023 proved to be a source of improvement. Venture financing increased from USD 725m to USD 841m. However, biotech financing retracted, with both the number and value of rounds decreasing. In the Biotech – Therapeutics and Diagnostics sector, oncology remains by far […]

27 Aug 2024

Switzerland Life Science Trend Analysis 2024

While the life sciences industry in Switzerland saw an overall decline in 2022, 2023 proved to be a source of improvement. Swiss biotechs raised USD 639 million, a 17% increase from the previous year. In Switzerland, 27% of all life science companies are biotechs, with a similar split between biotech therapeutics and diagnostics (45%) and […]

25 Jul 2024

France Life Science Trend Analysis 2024

The French life sciences industry continued to perform strongly in 2023, compared to other European countries like the Netherlands, Belgium, and Germany. Biotechnology companies make up 40% of the life sciences sector in France, with nearly half of these engaged in R&D services. Within the biotech – therapeutics and diagnostics sector, top key activities are […]

04 Jul 2024

UK Life Science Trend Analysis 2024

The UK government published the Science & Technology Framework in early 2023, signaling a robust strategy for the growth of the science and technology sector, with a focus on increasing private investment in R&D. Potentially a result of this strategic push, biotech private equity funding experienced a slight rise both in terms of the amount […]

17 Jun 2024

Norway Life Science Trend Analysis 2024

In 2023, the Norwegian life science industry continues to show dynamism and innovation. With biotechnology companies comprising a substantial 48% of the life science sector, nearly half of these fall under the “Biotech – Other” category, which includes sectors such as AgBio, environmental, veterinary, and industrial biotechnology. Notably, digital health emerges as a key sector, […]

07 Jun 2024

Taiwan Life Science Trend Analysis 2024

While 2023 shows a declining trend in terms of private equity financing of Taiwanese life science companies since 2020, public financing surged year-on-year, raising more than twice as much as in 2022. The three largest private equity financing rounds in 2023 were completed by medical technology companies, led by Syncell, which raised USD 8 million. […]

02 May 2024

Canadian Life Science Trend Analysis 2024

In 2023, the Canadian biotech landscape showed stability, largely maintaining the financing levels of the previous year (USD 451 million in 2023 vs. USD 460 million in 2022), but falling short of the record year of 2021. Ontario once again proved to be Canada’s most active province, with the highest number of biotech companies and […]

11 Apr 2024

Dutch Life Science Trend Analysis 2024: Market is slowly picking up

Biotechgate, the leading global biotech database, published their annual Trend Analysis Report 2024 of the Dutch life sciences sector in collaboration with hollandbio. In 2022, the Dutch biotech landscape saw a sharp 50% decline in venture financing, reflecting the challenging global economic climate. Fortunately, the tide seems to turn. In 2023, life sciences saw a […]

05 Apr 2024

Maryland Life Science Trend Analysis 2024

Venture financing for Maryland’s life sciences industry in 2023 shows signs of recovery following the significant downturn in 2022, with the total value of private equity financing reaching USD 805m (up from USD 639m in 2022). For the biotech industry, the value of venture financing deals remained stable (USD 453m in 2022 vs. USD 451m […]

21 Mar 2024

Norway Life Science Trend Analysis 2023

The Norwegian life sciences industry performed well in 2022 compared to the years before 2021 (2018 – 2020), raising USD 38 million in private equity investments according to Biotechgate data. However, it could not compete with the record level of venture financing in 2021 (USD 65 million). Cytovation ASA secured the largest round in 2022. […]

31 Aug 2023

Switzerland Life Science Trend Analysis 2023

Although shifts in the geopolitical landscape affected the Swiss life sciences industry in 2022, it resisted a major downturn in terms of private equity funding. Swiss biotech companies raised a total of USD 590 million in venture capital in 36 financing rounds. This is less than in the previous three years, but matches pre-COVID 19 […]

27 Jul 2023

Netherlands Life Science Trend Analysis 2023: A Difficult Year for Venture Financing

Tuesday, 04 July 2023 Biotechgate, the leading global biotech database, published their annual Trend Analysis Report 2023 of the Dutch life sciences sector. In 2022, compared to 2021, venture financing of life science and biotech companies went down by more than 50%. Furthermore, the year-to-year growth rate of new biotech ventures has been decreasing since 2018, with […]

05 Jul 2023

Maryland Life Science Trend Analysis 2023

Maryland’s life science private equity investment landscape in 2022 shifted back to levels seen prior to the exceptional growth experienced in 2021. The total value of life science venture financing in Maryland dropped from USD 1.2 billion in 2021 to half that amount in 2022, with USD 558 million invested. Looking at the top venture […]

28 Jun 2023

France Life Science Trend Analysis 2023

The Healthcare Innovation 2030 strategy, launched in 2021 and supported with USD 7.9 billion, aims to establish France as a European leader in the life sciences industry by promoting innovation and growth. One year on, this plan appears to be on track: Despite uncertain market conditions and unlike most other European countries, France was able […]

07 Jun 2023

Canada Life Science Trend Analysis 2023

Canadian biotech private equity investment has grown steadily over the past four years, but appears to have hit its peak in 2021 – in 2022, the value of biotech equity financings failed to match the record levels of the previous year (2022: USD 599 million vs. 2021: USD 841 million). Ontario is Canada’s most active […]

23 May 2023

UK Life Science Trend Analysis 2023

As one of the world’s top players in life sciences, the UK boasts a strong biotech sector, which accounts for 30% of the total UK life sciences industry. While half of biotech companies are primarily involved in R&D services, more than a third are therapeutics and diagnostics companies, and the remaining 15% are other biotechs […]

10 May 2023

Germany Life Science Trend Analysis 2023

After two strong years driven by the global pandemic, the German life sciences industry did not perform as well in terms of equity investment in 2022. As Biotechgate data shows, venture investment in biotech companies fell by almost half as compared to 2021, and with only USD 419 million in equity funding, is at its […]

17 Apr 2023

Taiwan Life Science Trend Analysis 2023

The biotech industry is one of Taiwan’s key industries that the Taiwanese government is actively promoting with the aim of strengthening international partnerships and growing export services. According to Biotechgate data, biotech companies account for 41% (263) of the total 640 life science companies in Taiwan. As for most other countries, the pandemic boosted the […]

16 Mar 2023

South Korea Life Science Trend Analysis 2022

In 2021, biotech companies account for 44% of the life sciences companies in South Korea. More than half of South Korean biotechs are part of the therapeutics and diagnostics sector, of which 19% are publicly listed on the stock exchange. The total value of venture financing for South Korean life sciences companies dropped by around […]

17 Aug 2022

Maryland Life Science Trend Analysis 2022

The life science industry in Maryland shows an upward trend in 2021, with an increase of 41% in private equity investment value of life science companies compared to the previous year. While there were 11 private equity rounds of biotech companies with a total investment of USD 302 million in 2020, the number of rounds […]

01 Jul 2022

Netherlands Life Science Trend Analysis 2022 – Time to Focus on Knowledge Transfer for Dutch Life Sciences Sector

Tuesday, 31 May 2022 Biotechgate, the leading global biotech database, published their annual Trend Analysis Report 2022 of the Dutch life sciences sector. In 2021 compared to 2020, new biotech companies grew with 2% and the amount of products in development in the (pre-)clinical phase increased with 22%. Although there is an increasing trend for […]

31 May 2022

Canada Life Science Trend Analysis 2022

In 2021, both Canadian and foreign investors closed overall larger venture capital deals than ever, resulting in an increasingly robust life science industry in Canada. In the Biotech – Therapeutics and Diagnostics sector alone, the three top financing deals were each worth at least 100 million USD. For more details on the Biotechgate data, see […]

29 Apr 2022

Denmark Life Science Trend Analysis 2022

The Danish life science industry continued its upward trend in 2021, reflecting the ongoing high priority of this industry for Denmark. While the number of biotech private equity financing rounds of 17 is as high as the previous year, a record amount of venture capital was raised in 2021, partly thanks to an exceptionally large […]

29 Apr 2022

France Life Science Trend Analysis 2022

2021 was a year of exceptional growth for the life science industry in France. In particular, biotech venture financing boomed in the second half of 2021 with a record USD 706 million in investment raised. Biotechgate data indicates a focus on on R&D services for the French biotech industry, being the largest biotech sector with […]

30 Mar 2022

Switzerland Life Science Trend Analysis 2022

As Biotechgate data shows, private equity investment rounds of life science companies increased by around 35% in 2021 compared to 2020. Despite venture investments in biotech companies declining slightly in 2021 compared to the strong previous annum, it was still a solid year for the biotech industry in Switzerland. Four of the five biotech companies […]

30 Mar 2022

United Kingdom Life Science Trend Analysis 2022

2021 was another record year for investments into UK life science companies.With a continued focus on tackling the COVID-19 pandemic, there was a remarkable increase in both the size and number of private financings compared to previous years. According to Biotechgate data for 2021, a record USD 3,138 million in venture capital was invested into […]

23 Mar 2022

Germany Life Science Market Trend Analysis 2022

While not reaching the levels of 2020 – the year COVID-19 became a top priority for life science sectors – the life science industry in Germany is still performing strongly. In 2021, it was second-highest in terms of private equity investment value since we started tracking the data. Germany has a strong focus on research […]

10 Mar 2022

Denmark Life Science Trend Analysis 2021

In 2020, the Danish life science industry noted the highest number of private equity investments ever, with three of them larger than 40 million US dollars. The number of companies is steadily growing, and there are now almost 600 Danish companies listed in the Biotechgate database. We would like to thank our partner, Copenhagen Capacity, […]

23 Jul 2021

Canada Life Science Market Trend Analysis 2021

In 2020, the total value of biotech equity financing in Canada, as well as the number of rounds, were slightly higher than in 2019 and the highest since 2016. Canadian companies currently have more than 700 human therapeutics in their pipelines and the country remains one of the strongest life science markets in the world. […]

25 May 2021

Germany Life Science Market Trend Analysis 2021

Even though most industries have been badly affected by the global pandemic, German life sciences thrived in 2020. The total value of private equity investments doubled compared to 2019 and was the highest since we started tracking the data. There are at least 840 human therapeutics in different stages of development which makes Germany one […]

19 May 2021

Switzerland Life Science Market Trend Analysis 2021

We are proud to present the annual life science market trend report for Switzerland that was compiled in cooperation with our partners: the Swiss Biotech Association, Basel Area Business & Innovation, Life Science Zurich, Canton of Zurich, and the City of Zurich. The report shows the thriving nature of the Swiss biotech industry that proved […]

26 Apr 2021

United Kingdom Life Science Trend Analysis 2021

2020 was a great year for the British biotech industry. The total value of private equity investments was twice as high compared to 2019 and exceeded the 2018 level that had been the highest since we begun tracking data. The UK remains the largest life science market in Europe when it comes to the number […]

29 Mar 2021

Dutch Life Sciences Trend Analysis 2021 – Biotech Companies Show To Be Resilient And See Venture Financing Grow In 2020

Wednesday, 3 March 2021 Biotechgate, the leading global biotech database, presents their annual Trend Analysis Report 2021 of the Dutch life sciences sector. The report shows the resilience of the Dutch biotech sector. Although the coronavirus had a negative impact on the amount of clinical trials, biotech companies attracted double the amount of venture […]

03 Mar 2021

Canadian Life Science Market Trend Analysis 2020

Together with our partners – Montreal Invivo, BioAlberta and BIOTECanada – we are happy to present an extended annual report on the Canadian life science market. Besides the usual statistics about companies, products and investments, the new format of the report includes data on clinical trials acquired from the new section of Biotechgate database.

28 Jul 2020

German Life Science Market Trend Analysis 2020

This month we are presenting the annual life science market trend report for Germany that was created thanks to the cooperation with our partners: BIO Deutschland, HEALTH MADE IN GERMANY, Cluster Biotechnology North Rhine-Westphalia, and BioRN. With about 1,200 active companies, over 500 assets available for licensing and 478 million dollars of venture capital attracted […]

29 Jun 2020

Dutch Life Science Market Trend Analysis 2020

Biotechgate presents the annual Trend Analysis Report 2020 for the Dutch life sciences sector. The report shows a stable number of life science companies and a sector which has grown in maturity. Biotech companies were successful in attracting venture capital; 2019 is a record year for venture financing.

25 Jun 2020

Denmark Life Science Market Trend Analysis 2020

The number of biotech companies in Denmark relative to the population is one of the highest in the world with Copenhagen being a very important European cluster. Last year Danish biotech was boosted with several large financing rounds with the volume as high as dozens of millions of dollars each. See the details in the […]

27 May 2020

Korean Life Science Market Trend Analysis 2020

South Korea is one of the most active life science markets in the world. In 2019, USD 806.7m was invested in Korean private biotech companies that accounted for almost 4% of the total global biotech financing amount. The country currently offers hundreds of biotech and medtech assets to out-licence. We would like to thank our […]

28 Apr 2020

Swiss Life Science Market Trend Analysis 2020

Our annual Swiss market trend analysis compiled with Biotechgate data shows that the life science industry in Switzerland is thriving. The amount of money raised in venture financing rounds in 2019 was nearly twice as large as in 2018. Also, more new biotech companies were launched last year than two years ago.

30 Mar 2020

UK Life Science Market Trend Analysis 2020

The number of financing rounds scored by UK private biotech companies in 2019 was the lowest since 2016. However, it still stays at a decent level and there is no sign of the British life science industry losing its position as the largest in Europe. Biotechgate lists more than 4,000 British companies that altogether have […]

28 Jan 2020

Canadian Life Science Market Trend Analysis 2019

This month we are presenting the annual trend report for the Canadian life science market that shows the strong position of the country in the global biotech industry. The total financing amount of the three largest rounds of 2019 alone exceeded a quarter billion USD. Download the report Would you like to be notified about […]

17 Dec 2019

German Life Sciences Market Trend Analysis 2019

We are proud to present the annual trend report for the German life sciences market. The report was compiled using data gathered from Biotechgate Business Development Database, in cooperation with our partners: HEALTH MADE IN GERMANY, BIO Deutschland, Cluster Biotechnology North Rhine-Westphalia, and BioValley Germany. Download the report Would you like to be notified about […]

31 Oct 2019

Thai Life Sciences Trend Analysis 2019

Last year we partnered with the Thai Ministry of Science and Technology and the Thailand Center of Excellence for Life Sciences (TCELS) to run the Thailand Life Sciences Database. Thanks to the partnership we have been able to enrich our database and create a market trend analysis and present it at the Bio Investment Asia […]

23 Sep 2019

Spanish Life Sciences Trend Analysis 2019

2018 was a booming year in Spanish biotech thanks to 77 USD mln of venture capital invested in the industry during this period. Two main financings rounds were scored by Catalan biopharma companies – Minoryx Therapeutics and Abac Therapeutics and the third one by AlgaEnergy – a Madrid based company specialized in microalgae technology. Download […]

25 Jun 2019

Dutch Life Sciences Trend Analysis 2019

With about 500 biotech companies registered, The Netherlands remain one of the strongest Life Science markets in Europe. The number of biotechs newly founded in 2018 was not as high as in previous years but the region is very far from stagnation. According to the data gathered in Biotechgate, over 100 million USD of venture […]

25 Jun 2019

Swiss Life Sciences Trend Analysis 2019

2018 was another very active year in the Swiss life sciences industry. The report compiled using the data from Biotechgate shows that the biotech financing was only slightly lower than in the record in 2017, while the total value of investments for the whole life science industry was even higher than in the previous year. […]

24 May 2019

UK Life Sciences Trend Analysis 2019

The United Kingdom is the largest European market when it comes to the number of life science companies. There are over 1,200 biotech companies based there with the total number of about 900 biopharmaceutical products being currently developed. 2018 was the record year in terms of the level of financing – 1,777 million USD was […]

24 Apr 2019

Danish Life Science Market Trend Analysis 2018

This month we are presenting the annual market trend analysis for the life sciences market in Denmark. Despite the small population, the country is a very important player in European biotech with Copenhagen and Medicon Valley being two of the most active clusters. Danish Life Science Trend Analysis 2018 Would you like to be notified […]

18 Dec 2018

Canadian Biotech Market Trend Analysis 2018

Biotechgate presents the annual life science and biotech market trend analysis for Canada. There are currently around thousand biotechnology and around a hundred pharma companies there, excluding subsidiaries of companies headquartered in other countries. The therapeutics sector is remarkably strong and three large financing round has been noted in the last 12 months. Canadian Biotech […]

23 Nov 2018

German Biotech Market Trend Analysis 2018

This month we are presenting a trend analysis of the German life sciences industry. The country remains one of the largest life sciences markets in the world with well over 3,000 companies listed in Biotechgate, out of which more than 1,000 are biotech entities. German biotech is well invested and the first half of 2018 […]

29 Oct 2018

Spain Life Science Trend Analysis 2018

Spanish Life Science Industry remains very dynamic with a particularly strong HealthTech (eHealth) sector; around half of the newly founded life science companies belong to this category. At the moment, there are 527 Biotech, 105 MedTech and 117 HealthTech companies in Spain, according to the data gathered by Biotechgate. The Bioregion of Catalonia is still […]

25 Jun 2018

Taiwan Life Science Trend Analysis 2018

This month we present our second annual life sciences trend report for Taiwan. The Taiwanese market is characterized by a strong presence of big pharma and a high percentage of publicly listed companies – nearly one in third life science enterprises in this country is listed on a stock market. There are around 200 biotech companies […]

13 Jun 2018

Dutch Life Sciences Trend Analysis 2018

The life sciences industry remains very strong in the Netherlands. It currently consist of about 1000 companies, half of which belong to the biotechnology sector. The majority of products in companies’ pipelines are in the area of oncology, followed by the products indicated for infectious diseases. In 2017, there were 12 major financing rounds in […]

21 May 2018

Swiss Life Sciences Trend Analysis 2018

2017 did not bring a lot of new life science companies to Switzerland. However, the total value of the venture financing of existing companies was twice as high as it was in 2016 with over 600 million USD invested. The largest amount went to ADC Therapeutics Inc and will be used to progress their products […]

23 Apr 2018

UK Life Sciences Trend Analysis 2018

The UK market remains one of the strongest in Europe. The total value of venture investments in biotech and other life science companies was lower in 2017 than in two previous years, but the number of financing rounds was impressive.

26 Mar 2018

Swedish Life Sciences Trend Analysis 2017

2017 was another very quiet year in Sweden. The downward trend from 2016 continued and only very few new Biotech companies were founded. Accordingly, a significant drop in the Biotech – and Life Science Venture Financing could be seen with a low number of overall financing rounds. Please click on the link below for the […]

19 Dec 2017

Denmark Life Sciences Trend Analysis 2017

This month, we are looking at the small but dynamic life sciences market in Denmark. The number of venture financing rounds and their total value have been smaller than previous years. However, the state of the market is far from stagnant with significant investments in the Danish biotech sector taking place in 2017 and a […]

29 Nov 2017

Canadian Life Sciences Trend Analysis 2017

This month we look at the Canadian life science market. 2016 was a particularly good year when it comes to investing in biotech companies there. The major financing rounds accumulated to over half a billion USD and we can see the continuation of the trend in 2017. Please click on the link below for the […]

30 Oct 2017

German Life Sciences Trend Analysis 2017

Compared to previous years, few new biotech companies were founded in Germany in 2016. However, the German life sciences industry remains strong and stable, due to a large number of already existing companies and the substantial financing rounds that have taken place. Please click on the link below for the full report. German LS Trend […]

30 Oct 2017

Dutch Life Sciences Trend Analysis 2017

Our annual trend report for the Dutch life sciences market shows that the country remains an important centre of the industry. There were 14 major financing rounds in the biotech sector in 2016 for the total amount of 71 million USD. However, the number of newly founded companies was much lower in 2016 than in […]

08 Jun 2017

Spain Life Sciences Trend Analysis 2017

2016 was a good year for the Spanish biotech industry, with 24 financing rounds for the total value of 38.8 million USD. At the moment, there are about twice as many biotech products undergoing clinical trials as there were at the beginning of the last year. As usual, Catalonia is the most active region. Spain […]

29 May 2017

Swiss Life Science Trend Analysis 2017

Our annual trend report for the Swiss life sciences market proves that Switzerland remains one of the most important locations in the life science industry. In 2016, Swiss biotechnology companies attracted funding worth nearly 400 million USD in total. Switzerland LS Trend Analysis 2017 Looking for your next Biotech or Medtech partner? Use Biotechgate to […]

26 Apr 2017

Taiwan Life Science Trend Analysis 2017

We look at the small but dynamic Taiwanese market in our first ever Taiwan life sciences trend analysis. The report was compiled in cooperation with our partner Taiwan Bio Industry Organisation. Taiwan LS Trend Analysis 2017 Looking for your next Biotech or Medtech partner? Use Biotechgate to identify new leads, licensing opportunities and management […]

25 Apr 2017

UK Life Sciences Trend Analysis 2017

2016 was a quiet year for the UK Life Science Industry. After the relatively good first half of the year when more than twenty financing rounds were noted with over USD 500m invested, the second half saw a significant drop in financing activities. UK Life Science Trend Analysis 2017 Looking for your next Biotech […]

28 Mar 2017

Swedish Life Sciences Trend Analysis 2016

In 2015 we saw a continuation of the downward trend when it comes to the number of new Biotech companies in Sweden. Also, the value of venture funds invested in the industry dropped dramatically and was about seven times smaller than in 2014. It changed, however, in the first half of 2016, when Aprea Ab […]

20 Dec 2016

French Life Sciences Trend Analysis 2016

In this month’s trend analysis we analyse the French Life Science industry. The private Biotech funding has been booming in H2 of 2015 and H1 of 2016, led by the USD 38.5m raised by MedDay Pharmaceuticals. However, the number of company foundations in 2016 has decreased compared to 2015. France LS Trend Analysis 2016 […]

29 Nov 2016

Danish Life Sciences Trend Analysis 2016

More biotech companies have been founded after stagnation in the last 2 years. However, 2016 has been slow in private Biotech funding. Danish LS Trend Analysis 2016 Looking for your next Biotech or Medtech partner? Use Biotechgate to identify new leads, licensing opportunities and management details. Get started now Learn more

26 Oct 2016

UK Life Sciences Trend Analysis 2015

2015 was a good year for Biotechnology Financing in the UK. Indeed the two semesters were stable at around 900m USD each. That is 10 times the amount of 2010 and over twice that of 2014. UK LS Trend Analysis 2015 Looking for your next Biotech or Medtech partner? Use Biotechgate to identify new […]

28 Jan 2016

Danish Life Sciences Trend Analysis 2015

The Danish venture financing remained stable from 2013 to 2015 at around USD 85m. However, private financing of Biotech companies showed a large intercompany variation. Danish LS Trend Analysis 2015 Looking for your next Biotech or Medtech partner? Use Biotechgate to identify new leads, licensing opportunities and management details. Get started now Learn more

22 Dec 2015

Sweden Life Sciences Trend Analysis 2015

After the best venture financing of Swedish Biotechnology Company of the last 5 years in 2014, the venture financing goes back to previous level in 2015 to date. The pipeline is maturing and renewing at the same time, with the number of products in phase II similar to the number of product in preclinical studies. […]

21 Dec 2015

German Life Sciences Trend Analysis 2015

Venture financing of German biotechnology companies drop to normal levels in 2015 following the best year for venture financing in the last 5 years. In the first half of 2015, close to USD 90m was raised in 5 financing rounds. German LS Trend Analysis 2015 Looking for your next Biotech or Medtech partner? Use […]

24 Nov 2015

French Life Sciences Trend Analysis 2015

Venture financing of French biotech companies is setting out to be very strong in the second half of this year, as it has already surpassed the levels seen in the second half of 2013 and 2014 respectively. France LS Trend Analysis 2015 Looking for your next Biotech or Medtech partner? Use Biotechgate to identify […]

06 Nov 2015

Life Science Trend Analysis 2015 for Italy

Venture financing of Italian biotech companies is picking up once again. In the first half of 2015 alone, USD 17.8M was raised, which is making it the second best half in 5 years. Life science venture financing was somewhat disappointing in 2014 compared to 2013 where USD 8.15M and USD 20.38M was raised respectively. Click […]

29 Sep 2015

Life Science Trend Analysis 2015 for Austria

With three rounds of financing and a combined value of USD 6.7M, 2014 proved to be a weak year for biotech financing in Austria. 2015 is set to look very different, as Austrian biotech financing gains momentum with an impressive USD 50M financing round to Nabriva to start off the first half of 2015. Click […]

29 Sep 2015

Dutch Life Sciences Trend Analysis 2015

3 Dutch companies, ProQR, UniQure and arGEN-X went public and raised approximately USD 272.5M combined. Nonetheless, the Biotech industry in the Netherlands has faced a drop in financing value of more than 50% whilst the number of rounds has decreased by 21%. The number of Biotech companies in the Netherlands has however increased significantly, from […]

05 Aug 2015

Spanish Life Sciences Trend Analysis 2015

The biotechnology venture sector faced over a 90% decrease in its financing value and a drop of 80% in financing rounds. Over the last three years the remarkable decrease in investments was continuing in 2014. But for the first half of 2015 (until May 2015) the number of investments in biotech ventures has increased by […]

08 Jul 2015

UK Life Sciences Trend Analysis 2014

2013 closed with the total venture financing value raised by Biotech companies in the U.K. being decreased by 47% compared to its 2012 level (USD 283m in 2013 compared to USD 530m in 2012). The number of U.K. biotech products (therapeutics and diagnostics) in the first stage of the clinical pipeline (Phase I) was increased […]

10 Dec 2014

Canadian Life Sciences Trend Analysis 2014

In 2013 the venture capital raised by Biotechnology companies in Canada almost doubled (93% increase) compared to the previous year’s figure, to reach a total of USD 139m. The majority of Biotech products in the industry belong to the area of oncology, followed by products developed for nervous system and for Infectious diseases indications. Distributors, […]

26 Nov 2014

Danish Life Sciences Trend Analysis 2014

In 2013, the total venture financing value amassed by Danish Biotechnology companies was by 64% increased compared to the previous year’s figure (USD 82m in 2013 compared to USD 50m in 2012). This summer’s snapshot of the Danish biotech industry reveals that 1 in 10 biotech companies are publicly traded; a 4 percentage point increase […]

19 Nov 2014

Swedish Life Sciences Trend Analysis 2014

2013 saw the Swedish Biotech Industry raising a significantly smaller venture financing amount than in the year before (USD 27m compared to USD 127m in 2012). During the same period the number of companies achieving an IPO exit doubled. The number of biotech products in Phase I of development remained stable compared to last year, […]

13 Nov 2014

French Life Sciences Trend Analysis 2014

The number of Biotech (Therapeutics and Diagnostics) companies founded in France in 2013 was double that of the previous year. At the same time, the 2013 total venture financing value was increased for a third consecutive year, reaching USD 197m; 30% higher than in 2012 (USD 151m). Click here to download French Life Sciences Trend […]

29 Oct 2014

German Life Sciences Trend Analysis 2014

In 2013, the total financing value raised by private, Biotech companies in Germany was reduced by 31% compared to last year’s figure (USD 210m from what was USD 305m in 2012). However, this summer’s snapshot of the German biotech industry, suggests that the therapeutics pipeline is revitalized, since the number of products in earlier stages […]

29 Oct 2014

Swiss Life Sciences Trend Analysis 2014

While the number of Swiss Biotech companies in 2013 remained close to its 2012 levels, the total financing value amassed within the sector more than doubled compared to last year’s figure, reaching USD 325m (112% increase). Click here to download Swiss Life Sciences Trend Analysis 2014 – 14 pages Looking for your next Biotech or […]

24 Sep 2014

Spanish Life Sciences Trend Analysis 2014

Biotech financing activity in Spain in 2013 was slower compared to 2012 (43% fewer financing rounds and no IPOs). Nevertheless, the total financing value raised by Biotechs increased by approximately 10% during the same period. Click here to download Spanish Life Sciences Trend Analysis 2014 – 14 pages Looking for your next Biotech or Medtech […]

24 Sep 2014

Swedish Life Sciences Trend Analysis 2013

Swedish Life Sciences Trend Analysis 2013 – 12 pages

14 Jun 2013

German Life Sciences Trend Analysis 2012

German Life Sciences Trend Analysis 2012 English (PPT) – 13 Pages – 811 kb

24 May 2012

Canadian Life Sciences Trend Analysis 2012

Canadian Life Sciences Trend Analysis 2012 English (PPT) – 13 Pages – 920 kb

24 May 2012

UK Life Sciences Trend Analysis 2012

UK Life Sciences Trend Analysis 2012 English (PPT) – 13 Pages – 937 kb

24 May 2012

French Life Sciences Trend Analysis 2012

French Life Sciences Trend Analysis 2012 English (PPT) – 13 Pages – 898 kb

24 May 2012

Swiss Life Sciences Trend Analysis 2012

With five new Biotech Therapeutic and Diagnostic companies starting up last year, Switzerland secured its place as one of the premier biotech countries in the world. Currently the leader in biotech employee’s per capita the Swiss Biotech industry outperformed in a year where the majority of countries struggled. Lead by Biocartis, the Swiss Biotech sector […]

24 May 2012

Austrian Life Sciences Statistics 2011

Austrian Life Sciences Survey 2011 Austrian Life Sciences Survey 2011 (ppt – 588kb)

02 Nov 2011

Canadian Life Sciences Statistics 2011

Canadian Life Sciences Survey 2011 Canadian Life Sciences Survey 2011 (ppt – 680kb)

02 Nov 2011

French Life Sciences Statistics 2011

French Life Sciences Survey 2011 French Life Sciences Survey 2011 (ppt – 604kb)

02 Nov 2011

German Life Sciences Statistics 2011

German Life Science Survey 2011 German Life Science Survey 2011 (ppt – 612kb)

21 Oct 2011

Italian Life Sciences Statistics 2011

Italian Life Sciences Statistics 2011 Italian Life Sciences Statistics 2011 (ppt – 599kb)

25 Aug 2011

Swiss Life Sciences Statistics 2011

Swiss Life Sciences Statistics 2011 Swiss Life Sciences Statistics 2011 (ppt – 596kb)

25 Aug 2011

UK Life Sciences Statistics 2011

UK Life Sciences Statistics 2011 UK Life Sciences Statistics 2011 (ppt – 682kb)

25 Aug 2011

French Life Sciences Statistics 2009-2010

French Life Sciences Survey 2009-2010 French Life Sciences Statistics 2009-2010 (ppt – 584kb)

02 Nov 2010

Austrian Life Sciences Statistics 2009-2010

Austrian Life Sciences Statistics 2009-2010 Austrian Life Sciences Survey 2009-2010 (ppt – 584kb)

02 Nov 2010

Italian Life Sciences Statistics 2009 – 2010

Italian Life Sciences Statistics 2009 – 2010 Italian Life Sciences Statistics 2009 – 2010 (ppt – 584kb)

25 Aug 2010

Swiss Life Sciences Statistics 2009 – 2010

Swiss Life Sciences Statistics 2009 – 2010 Swiss Life Sciences Statistics 2009 – 2010 (ppt – 584kb)

25 Aug 2010

UK Life Sciences Statistics 2009 – 2010

UK Life Sciences Statistics 2009 – 2010 UK Life Sciences Statistics 2009 – 2010(ppt – 584kb)

25 Aug 2010

German Life Sciences Statistics 2009 – 2010

German Life Science Statistics 2009 – 2010 German Life Sciences Statistics 2009-10 (ppt – 586kb)

21 Aug 2010

Canadian Life Sciences Statistics 2009

Canadian Life Sciences Survey 2009 Canadian Life Sciences Survey 2009 (ppt – 720kb)

02 Nov 2009

Austrian Life Sciences Statistics 2008

Austrian Life Sciences Survey 2008 Austrian Life Sciences Survey 2008 (ppt – 420kb)

02 Nov 2008

Canadian Life Sciences Statistics 2008

Canadian Life Sciences Survey 2008 Canadian Life Sciences Survey 2008 (ppt – 419kb)

02 Nov 2008

French Life Sciences Statistics 2008

French Life Sciences Statistics 2008 French Life Sciences Survey 2008 (ppt – 437kb)

02 Nov 2008

German Life Sciences Statistics 2008

German Life Sciences Statistics 2008 German Life Sciences Statistics 2008 (ppt – 1’002kb)

25 Aug 2008

Italian Life Sciences Statistics 2008

Italian Life Sciences Survey 2008 Italian Life Sciences Survey 2008 (ppt – 442kb)

25 Aug 2008

Swiss Life Sciences Statistics 2008

Swiss Life Sciences Survey 2008 Swiss Life Sciences Survey 2008 (ppt – 542kb)

25 Aug 2008

UK Life Sciences Statistics 2008

UK life Sciences Survey 2008 UK Life Sciences Survey 2008 (ppt – 840kb)

25 Aug 2008

Italian Life Sciences Statistics 2007

Italian Life Sciences Survey 2007 Italian Life Sciences Survey 2007 (ppt – 408kb)

25 Aug 2007

Swiss Life Sciences Statistics 2007

Swiss Life Sciences Survey 2007 Swiss Life Sciences Survey 2007 (ppt – 536kb)

25 Aug 2007

Italian Life Sciences Statistics 2006

Italian Life Sciences Survey 2006 Italian Life Sciences Survey 2006 (ppt – 313kb)

25 Aug 2006

Swiss Life Sciences Statistics 2006

Swiss Life Sciences Survey 2006 Swiss Life Sciences Survey 2006 (ppt – 656kb)

25 Aug 2006

Swiss Life Sciences Statistics 2004

Swiss Life Sciences Survey 2004 Swiss Life Sciences Survey 2004 (ppt – 272kb)

25 Aug 2004